Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure
Anticancer Research · 2026
DOI: 10.21873/anticanres.18032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Eshat F Haque und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine, Izumo, Japan. Hauptthemen laut MEDLINE: Pemetrexed, Mutation, Protein Kinase Inhibitors, Carcinoma, Non-Small-Cell Lung.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
- Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine, Izumo, Japan okimoto@med.shimane-u.ac.jp.
Zitieren
APA
Haque, E. F., Tanino, R., Okimoto, T., Hotta, T., Okuno, T., Kono, K., Tsubata, Y., & Isobe, T. (2026). Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure. Anticancer Research. https://doi.org/10.21873/anticanres.18032
Vancouver
Haque EF, Tanino R, Okimoto T, Hotta T, Okuno T, Kono K, et al. Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure. Anticancer Research. 2026. doi:10.21873/anticanres.18032
BibTeX
@article{Haque2026,
author = {Haque, Eshat F and Tanino, Ryosuke and Okimoto, Tamio and Hotta, Takamasa and Okuno, Takae and Kono, Kento and Tsubata, Yukari and Isobe, Takeshi},
title = {Concurrent Pemetrexed With EGFR-TKI Slows the Accumulation of De Novo Mutations During In Vitro Exposure},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18032}
}
EUVIMED